Expression profiles and prognostic value of miRNAs in retinoblastoma Lara Elis Alberici DelsinKarina Bezerra SalomaoMaria Sol Brassesco Review – Cancer Research 22 October 2018 Pages: 1 - 10
Multiple functions of HuR in urinary tumors Fa ZhangZhonglin CaiFenghai Zhou Review – Cancer Research 28 October 2018 Pages: 11 - 18
Novel positioning from obesity to cancer: FTO, an m6A RNA demethylase, regulates tumour progression JiaLing ChenBin Du Review – Cancer Research 21 November 2018 Pages: 19 - 29
Multidimensional communication of microRNAs and long non-coding RNAs in lung cancer Tingting GuoJunyao LiPeng Gao Review – Cancer Research 11 November 2018 Pages: 31 - 48
Microbiota in cancer development and treatment Muhammad Hassan RazaKamni GulMuhammad Arshad Review – Cancer Research 12 December 2018 Pages: 49 - 63
FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma Chang LiuZhi LiXiujuan Qu Original Article – Cancer Research 24 October 2018 Pages: 65 - 76
FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancer Felix HarpainMohamed A. AhmedGerd R. Silberhumer Original Article – Cancer Research Open access 01 October 2018 Pages: 77 - 86
G-protein-coupled estrogen receptor suppresses the migration of osteosarcoma cells via post-translational regulation of Snail Zhen WangXiao ChenJia Zheng Original Article – Cancer Research 20 October 2018 Pages: 87 - 96
Combination of gold nanoparticles with low-LET irradiation: an approach to enhance DNA DSB induction in HT29 colorectal cancer stem-like cells Mahdi AbbasianAzam BaharloueiDavid A. Lightfoot Original Article – Cancer Research 19 October 2018 Pages: 97 - 107
A novel prognostic signature of seven genes for the prediction in patients with thymoma Qiang LiYan-Ling SuWei-Xi Shen Original Article – Cancer Research Open access 17 October 2018 Pages: 109 - 116
DA-EPOCH-R improves the outcome over that of R-CHOP regimen for DLBCL patients below 60 years, GCB phenotype, and those with high-risk IPI, but not for double expressor lymphoma Xin-Yu ZhangJin-Hua LiangWei Xu Original Article – Cancer Research 16 October 2018 Pages: 117 - 127
Trofosfamide in the treatment of elderly or frail patients with diffuse large B-cell lymphoma Hanno M. WitteArmin RieckeNiklas Gebauer Original Article – Cancer Research 16 October 2018 Pages: 129 - 136
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines Simona CameroSimona CeccarelliCarlo Dominici Original Article – Cancer Research Open access 24 October 2018 Pages: 137 - 152
mTOR and mTOR phosphorylation status in primary and metastatic renal cell carcinoma tissue: differential expression and clinical relevance Steffen RauschDaniel SchollenbergerJens Bedke Original Article – Cancer Research 27 October 2018 Pages: 153 - 163
Novel therapeutic compound acridine–retrotuftsin action on biological forms of melanoma and neuroblastoma Miroslawa CichorekAnna RonowskaKrystyna Dzierzbicka Original Article – Cancer Research Open access 26 October 2018 Pages: 165 - 179
Primary anatomical site, adjuvant therapy, and other prognostic variables for dedifferentiated liposarcoma Jonathan GooteeSarah AuritPeter Silberstein Original Article – Cancer Research 25 October 2018 Pages: 181 - 192
First experience and clinical results using a new non-coplanar mono-isocenter technique (HyperArc™) for Linac-based VMAT radiosurgery in brain metastases Filippo AlongiAlba FiorentinoRuggero Ruggieri Original Article – Cancer Research 31 October 2018 Pages: 193 - 200
Advanced adenoid cystic carcinoma (ACC) is featured by SWI/SNF chromatin remodeling complex aberrations Beata JagielskaElzbieta SarnowskaJanusz A. Siedlecki Original Article – Cancer Research Open access 31 October 2018 Pages: 201 - 211
Surgical staging in endometrial cancer Maria Luisa GasparriDonatella CasertaMichael D. Mueller Review – Clinical Oncology 20 November 2018 Pages: 213 - 221
Fecal volatile organic compounds for early detection of colorectal cancer: where are we now? Sofie BoschDaniel J. BerkhoutNanne K. de Boer Review – Clinical Oncology 15 December 2018 Pages: 223 - 234
Apatinib as maintenance therapy in extensive-stage small-cell lung cancer: results from a single-center retrospective study Xiangtao YanQiming WangZhiyong Ma Original Article – Clinical Oncology Open access 06 October 2018 Pages: 235 - 240
Intratumor heterogeneity and tissue distribution of KRAS mutation in non-small cell lung cancer: implications for detection of mutated KRAS oncogene in exhaled breath condensate Jacek KordiakJanusz SzemrajDariusz Nowak Original Article – Clinical Oncology Open access 27 October 2018 Pages: 241 - 251
Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers Fabian FinkelmeierCarolin CzaudernaOliver Waidmann Original Article – Clinical Oncology 29 October 2018 Pages: 253 - 259
Short-term intra-arterial infusion chemotherapy for head and neck cancer patients maintaining quality of life Karl R. AignerEmir SelakKornelia Aigner Original Article – Clinical Oncology Open access 31 October 2018 Pages: 261 - 268
Differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal carcinoma with the assistance of next-generation sequencing and immunohistochemistry Jie ZhangChan XiangKeke Yu Original Article – Clinical Oncology 10 November 2018 Pages: 269 - 279
